• Epoxomicin and the Proteasome Logic of Viral Inflammation

  2026-09-22

  Viral immune evasion is often framed as a signaling problem, but the targeted destruction of RIPK3 shows why protein turnover deserves equal attention. This thought-leadership analysis explains how Epoxomicin can help translational researchers test proteasome dependence in virus-induced inflammation, design more rigorous protein degradation assays, and distinguish mechanistic evidence from therapeutic promise.

• How Cholesterol Hinders LNP Intracellular Trafficking

  2026-09-22

  A 2025 study developed a sensitive imaging platform to distinguish LNP uptake from productive intracellular trafficking of nucleic acid cargo. Its results show that increasing cholesterol can promote aggregation of LNP-containing peripheral early endosomes, restricting access to downstream endolysosomal compartments and reducing delivery efficiency.

• Protease Inhibitor Cocktail for ENaC Processing

  2026-09-21

  The Protease Inhibitor Cocktail helps preserve ENaC cleavage states during kidney protein extraction. This article connects EDTA-free protease control with the interpretation of salt- and ADH-dependent trafficking experiments, offering practical guidance for phosphorylation-compatible assays and protease inhibition in cell lysates.

• Trichostatin A (TSA) for Epigenetic Assays

  2026-09-21

  Trichostatin A (TSA) provides a reversible HDAC-inhibition strategy for linking histone acetylation with cancer-cell growth, differentiation, and cell-cycle phenotypes. This guide turns TSA into a controlled workflow while showing how activity-based HO-1 imaging can add an orthogonal readout without overstating the evidence.

• Low-Dose Cadmium Activates STAT3 in Lymphangiogenesis

  2026-09-20

  The reference study shows that low-dose cadmium enhances injury-associated corneal lymphangiogenesis by activating STAT3 in lymphatic endothelial cells and increasing VEGFR3 expression. Its combination of an in vivo alkali-burn model, human endothelial-cell assays, pathway profiling, and pharmacological STAT3 inhibition provides a useful framework for interpreting toxicant-driven lymphatic remodeling.

• Dehydroepiandrosterone (DHEA) Lab Workflows

  2026-09-19

  A scenario-driven guide to using Dehydroepiandrosterone (DHEA), SKU B1375, in cell viability, neuroprotection, apoptosis, and ovarian research. It connects concentration selection, solvent control, PCOS-model interpretation, and practical vendor evaluation to documented product and literature evidence.

• Trichostatin A (TSA): Assays for Epigenetic Research

  2026-09-18

  Build controlled HDAC-inhibition workflows with Trichostatin A (TSA) for chromatin, cancer, differentiation, and senescence studies. This guide connects practical histone-acetylation assays with the TERC-53 senescence pathway while separating established evidence from testable extensions.

• Sumatriptan Succinate in Translational Migraine Research

  2026-09-18

  Sumatriptan combines clinically relevant 5-HT1B/1D pharmacology with practical workflows for receptor, inflammation, and metabolism studies. This guide translates pediatric emergency pathway findings into reproducible assay design, dose selection, and troubleshooting decisions.

• 10 mM dNTP mixture for PCR & DNA Synthesis

  2026-09-17

  A practical guide to using an equimolar 10 mM dNTP mixture across PCR, qPCR, sequencing preparation, and reporter-DNA workflows. It combines reagent-handling discipline with assay-design lessons from recent LNP delivery research, helping researchers separate nucleotide quality from cell-state and nanoparticle variables.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer

  2026-09-17

  A 2026 FASEB Journal study developed chemically modified p21 mRNA in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored tumor-suppressor activity, altered cell-cycle and DNA-damage pathways, and suppressed orthotopic tumor growth while limiting systemic distribution in mice.

• RBMS1, PD-L1, and Immune Escape in TNBC

  2026-09-16

  The reference study identifies RBMS1 as an immune-cold triple-negative breast cancer regulator that sustains PD-L1 through B4GALT1 mRNA stability and PD-L1 glycosylation. Its findings support RBMS1 depletion as a strategy for improving T-cell-based therapies, while also illustrating how protein stability and turnover can be tested in complementary workflows.

• Ganetespib (STA-9090): Hsp90 Research Guide

  2026-09-16

  Ganetespib (STA-9090) is a triazolone-containing Hsp90 inhibitor with nanomolar activity in selected cancer models. Its documented value in cancer research is strongest as a mechanistic and assay tool, while its reported antiviral relevance remains unestablished.

• Troxerutin, TRPM7, and Diabetic Cognitive Dysfunction

  2026-09-15

  This study identifies a TRPM7–calcineurin–Drp1^Ser637 pathway that links calcium dysregulation to mitochondrial fission, neuronal apoptosis, and diabetic cognitive dysfunction. Using diabetic mice and high-glucose hippocampal neurons, the authors show that troxerutin improves behavioral and cellular outcomes by suppressing this pathway, while also highlighting experimental strategies for testing mitochondrial mechanisms in diabetes-related neurocognitive disease.

• EZH2 Inhibition and 5-Azacytidine in PTEN-Deficient GBM

  2026-09-15

  Zhu et al. show that PTEN-deficient glioblastoma suppresses the ERV–MAVS–type I interferon axis, limiting immune surveillance and reducing the response to 5-Azacytidine monotherapy. Combining 5-Azacytidine with EZH2 inhibition lowers H3K27me3, reactivates endogenous retroviruses, and remodels the tumor microenvironment toward stronger antitumor immunity.

• Doxycycline Hyclate for MMP-2/9 BBB Research

  2026-09-14

  Doxycycline hyclate is a matrix metalloproteinases inhibitor that can help dissect MMP-driven blood–brain barrier injury. This article moves beyond product description to explain how integrated behavioral, vascular, molecular, and formulation controls improve mechanistic interpretation.

8152 records 1/544 page Next 12345 下5页 Last page